Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB (change energy unit to kcal/mol)
Found 532 hits in this display
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
IC50: 100nMAssay Description:Inhibition of CDK2/cyclin E (unknown origin) expressed in baculovirus infected Sf21 insect cells in presence of [gamma33P]ATPMore data for this Ligand-Target Pair
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
Cyclin-C(Homo sapiens (Human))The People'S Hospital Of Xinjiang Uyghur Autonomous Region
Curated by ChEMBL
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
IC50: 100nMAssay Description:Inhibition of CDK2/cyclin E (unknown origin) expressed in Sf9 cells using histone H1 as substrate in presence of [gamma33P]ATPMore data for this Ligand-Target Pair
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
IC50: 158nMAssay Description:Inhibition of CDK2/Cyclin E (unknown origin) expressed in sf9 cells using histone H1 as substrate in presence of [gamma33P]-ATPMore data for this Ligand-Target Pair
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
IC50: 200nMAssay Description:Inhibition of bovine brain CDK5 using histone H1 as substrate incubated for 15 mins in presence of [gamma-32P]ATP by radiometric scintillation assayMore data for this Ligand-Target Pair
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
IC50: 200nMAssay Description:Inhibitory activity against purified cdc2 p34/Cyclin B obtained from M phase oocytes of the starfish Marthasterias glacialis.More data for this Ligand-Target Pair
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
IC50: 230nMpH: 7.5 T: 2°CAssay Description:In vitro kinase assay using purified enzyme, was incubated at 30 °C with substrate, and test compounds in the presence of 15 uM ATP/ [gamma-33P]...More data for this Ligand-Target Pair
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
IC50: 270nMAssay Description:Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into peptide PKTPKKAKKL substrate after 45 mins by scintillation counterMore data for this Ligand-Target Pair
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
IC50: 270nMpH: 7.5 T: 2°CAssay Description:In vitro kinase assay using purified enzyme, was incubated at 30 °C with substrate, and test compounds in the presence of 15 uM ATP/ [gamma-33P]...More data for this Ligand-Target Pair
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
IC50: 280nMAssay Description:Inhibition of human recombinant CDK5/p25 using [gamma-33P]ATP after 30 mins incubation by scintillation counting analysisMore data for this Ligand-Target Pair
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
IC50: 280nMAssay Description:Inhibition of CDK5/p25 assessed as [33P]gamma-ATP incorporation into biotinylated PKTPKKAKKL substrate after 60 mins by scintillation countingMore data for this Ligand-Target Pair
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
IC50: 330nMpH: 7.5 T: 2°CAssay Description:In vitro kinase assay using purified enzyme, was incubated at 30 °C with substrate, and test compounds in the presence of 15 uM ATP/ [gamma-33P]...More data for this Ligand-Target Pair
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
IC50: 350nMpH: 7.2 T: 2°CAssay Description:Kinase activities were assayed in buffers containing substrate, enzyme, and inhibitor at 30 °C in the presence of 15 uM ATP/[gamma-32P] ATP. 32P...More data for this Ligand-Target Pair
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
IC50: 400nMpH: 7.2 T: 2°CAssay Description:Kinase activities were assayed in buffers containing substrate, enzyme, and inhibitor at 30 °C in the presence of 15 uM ATP/[gamma-32P] ATP. 32P...More data for this Ligand-Target Pair
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
IC50: 450nMpH: 7.2 T: 2°CAssay Description:Kinase activities were assayed in buffers containing substrate, enzyme, and inhibitor at 30°C in the presence of 15 uM ATP/[gamma-32P] ATP. 32P ...More data for this Ligand-Target Pair
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
IC50: 700nMAssay Description:Inhibition of GST-fused CDK2/cyclin A (unknown origin) expressed in baculovirus infected Sf9 cells after 10 min in presence of [gamma-32PP]ATPMore data for this Ligand-Target Pair
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
IC50: 700nMAssay Description:Inhibition of GST-fused CDK2/cyclin E (unknown origin) expressed in baculovirus infected Sf9 cells after 10 min in presence of [gamma-32PP]ATPMore data for this Ligand-Target Pair
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
IC50: 800nMpH: 7.5 T: 2°CAssay Description:In vitro kinase assay using purified enzyme, was incubated at 30 °C with substrate, and test compounds in the presence of 15 uM ATP/ [gamma-33P]...More data for this Ligand-Target Pair
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
IC50: 2.40E+3nMAssay Description:Inhibition of recombinant CDK1/cyclin B (unknown origin) using histone H1 as substrate in presence of [gamma-33P]ATPMore data for this Ligand-Target Pair
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
IC50: >1.00E+4nMAssay Description:Inhibition of porcine brain GSK3 using GS-1 as substrate after 30 mins in presence of [gamma-33P] by scintillation counting methodMore data for this Ligand-Target Pair
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
IC50: 1.10E+4nMpH: 7.2 T: 2°CAssay Description:Kinase activities were assayed in buffers containing substrate, enzyme, and inhibitor at 30 °C in the presence of 15 uM ATP/[gamma-32P] ATP. 32P...More data for this Ligand-Target Pair
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
IC50: 2.20E+4nMpH: 7.2 T: 2°CAssay Description:Kinase activities were assayed in buffers containing substrate, enzyme, and inhibitor at 30 °C in the presence of 15 uM ATP/[gamma-32P] ATP. 32P...More data for this Ligand-Target Pair
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
IC50: >1.00E+5nMAssay Description:Inhibition of recombinant Abl kinase (unknown origin) expressed in Sf9 cells using GGEAIYAAPFKK as substrate in presence of [gamma33P]ATPMore data for this Ligand-Target Pair
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
IC50: 1.00E+5nMpH: 7.2 T: 2°CAssay Description:Kinase activities were assayed in buffers containing substrate, enzyme, and inhibitor at 30 °C in the presence of 15 uM ATP/[gamma-32P] ATP. 32P...More data for this Ligand-Target Pair
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
IC50: 1.70E+5nMAssay Description:Inhibition of MAPK8 (unknown origin) using peptide as substrate after 3 hrs by kinase-glo luminescent assay relative to controlMore data for this Ligand-Target Pair
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
IC50: >1.00E+6nMT: 2°CAssay Description:Kinase activities were assayed in buffers containing substrate, enzyme, and inhibitor at 30°C in the presence of 15 uM ATP/[gamma-32P] ATP. 32P ...More data for this Ligand-Target Pair
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
Kd: 1.80E+3nMpH: 7.4 T: 2°CAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
Kd: 1.20E+3nMpH: 7.4 T: 2°CAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
EC50: 2.76E+4nMAssay Description:Agonist activity at N-type Cav2.2 channel expressed in tsA201 cell assessed as calcium current by whole-cell patch clamp methodMore data for this Ligand-Target Pair
BDBM7533((2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]am...)
Displayed 1 to 50 (of 532 total ) | Next | Last >>